Hiberix

Hiberix is a booster vaccine that provides protection against invasive diseases caused by Haemophilus influenzae type b (Hib) bacteria. It is typically given as a single booster dose for children ages 15 months through four years of age. Potential side effects of the vaccine include fever, fussiness, and injection site skin reactions.

Hiberix^® (Hib vaccine) is a childhood vaccine. It is approved as a booster vaccine for children 15 months old through four years old (before the fifth birthday). This vaccine provides protection against Haemophilus influenzae type b (Hib), a type of bacteria that can cause potentially life-threatening diseases.

 

Hiberix (approved by the Food and Drug Administration in August 2009) is a much-welcomed addition to the group of available Hib vaccines, since it helps to increase the supplies of Hib vaccine after a considerable shortage. The booster Hib dose was temporarily postponed for almost all children during the shortage but has been reinstated (as of June 2009).

 

 

Hiberix does not contain thimerosal (a mercury-containing preservative). Parents who are concerned about exposing their children to thimerosal can be confident that this vaccine has no thimerosal (not even trace amounts). Some parents are concerned about the aluminum content of vaccines; Hiberix does not contain aluminum.

 

Hiberix is not made from human fetal components or animal components, as some vaccines are.

 

123Next >>